title: Localizations of Na(+)-D-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart.
abstract: Novel affinity-purified antibodies against human SGLT1 (hSGLT1) and SGLT2 (hSGLT2) were used to localize hSGLT2 in human kidney and hSGLT1 in human kidney, small intestine, liver, lung, and heart. The renal locations of both transporters largely resembled those in rats and mice; hSGLT2 and SGLT1 were localized to the brush border membrane (BBM) of proximal tubule S1/S2 and S3 segments, respectively. Different to rodents, the renal expression of hSGLT1 was absent in thick ascending limb of Henle (TALH) and macula densa, and the expression of both hSGLTs was sex-independent. In small intestinal enterocytes, hSGLT1 was localized to the BBM and subapical vesicles. Performing double labeling with glucagon-like peptide 1 (GLP-1) or glucose-dependent insulinotropic peptide (GIP), hSGLT1 was localized to GLP-1-secreting L cells and GIP-secreting K cells as has been shown in mice. In liver, hSGLT1 was localized to biliary duct cells as has been shown in rats. In lung, hSGLT1 was localized to alveolar epithelial type 2 cells and to bronchiolar Clara cells. Expression of hSGLT1 in Clara cells was verified by double labeling with the Clara cell secretory protein CC10. Double labeling of human heart with aquaporin 1 immunolocalized the hSGLT1 protein in heart capillaries rather than in previously assumed myocyte sarcolemma. The newly identified locations of hSGLT1 implicate several extra renal functions of this transporter, such as fluid absorption in the lung, energy supply to Clara cells, regulation of enteroendocrine cells secretion, and release of glucose from heart capillaries. These functions may be blocked by reversible SGLT1 inhibitors which are under development.
authors.affiliation: Molecular Toxicology Unit, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, 10000, Zagreb, Croatia.
authors.forename: Ivana
authors.initials: I
authors.lastname: Vrhovac
authors.forename: Daniela
authors.initials: D
authors.lastname: Balen Eror
authors.forename: Dirk
authors.initials: D
authors.lastname: Klessen
authors.forename: Christa
authors.initials: C
authors.lastname: Burger
authors.forename: Davorka
authors.initials: D
authors.lastname: Breljak
authors.forename: Ognjen
authors.initials: O
authors.lastname: Kraus
authors.forename: Nikola
authors.initials: N
authors.lastname: Radović
authors.forename: Stipe
authors.initials: S
authors.lastname: Jadrijević
authors.forename: Ivan
authors.initials: I
authors.lastname: Aleksic
authors.forename: Thorsten
authors.initials: T
authors.lastname: Walles
authors.forename: Christoph
authors.initials: C
authors.lastname: Sauvant
authors.forename: Ivan
authors.initials: I
authors.lastname: Sabolić
authors.forename: Hermann
authors.initials: H
authors.lastname: Koepsell
mesh_terms: D000328:Adult; D015153:Blotting, Western; D005260:Female; D006321:Heart; D006801:Humans; D007150:Immunohistochemistry; D007421:Intestine, Small / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D020133:Reverse Transcriptase Polymerase Chain Reaction; D051269:Sodium-Glucose Transporter 1 / Q000032:analysis / Q000096:biosynthesis*; D051297:Sodium-Glucose Transporter 2 / Q000032:analysis / Q000096:biosynthesis*
chemical_list: C495674:SLC5A1 protein, human; C089180:SLC5A2 protein, human; D051269:Sodium-Glucose Transporter 1; D051297:Sodium-Glucose Transporter 2